Publication Date
In 2025 | 1 |
Since 2024 | 6 |
Descriptor
Source
Research Synthesis Methods | 2 |
Autism: The International… | 1 |
Journal of Attention Disorders | 1 |
Journal of Autism and… | 1 |
Prevention Science | 1 |
Author
Georgia Salanti | 2 |
Alba Realpe | 1 |
Amy L. Mahony | 1 |
Andrea Cipriani | 1 |
Andrea Manca | 1 |
Brian Cornblatt | 1 |
C. Jean Choi | 1 |
Cale Basaraba | 1 |
Chiara Zecca | 1 |
Christina A. Brezing | 1 |
Clara Miguel | 1 |
More ▼ |
Publication Type
Journal Articles | 6 |
Reports - Research | 5 |
Information Analyses | 2 |
Reports - Descriptive | 1 |
Education Level
Audience
Location
China | 1 |
New York | 1 |
United Kingdom | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Konstantina Chalkou; Tasnim Hamza; Pascal Benkert; Jens Kuhle; Chiara Zecca; Gabrielle Simoneau; Fabio Pellegrini; Andrea Manca; Matthias Egger; Georgia Salanti – Research Synthesis Methods, 2024
Some patients benefit from a treatment while others may do so less or do not benefit at all. We have previously developed a two-stage network meta-regression prediction model that synthesized randomized trials and evaluates how treatment effects vary across patient characteristics. In this article, we extended this model to combine different…
Descriptors: Medical Research, Outcomes of Treatment, Risk, Randomized Controlled Trials
Jianjun Ou; Robert C. Smith; Russell H. Tobe; Jingjing Lin; Jen Arriaza; Jed W. Fahey; Ruiting Liu; Ying Zeng; Yanan Liu; Lian Huang; Yidong Shen; Yamin Li; Daomeng Cheng; Brian Cornblatt; John M. Davis; Jingping Zhao; Renrong Wu; Hua Jin – Journal of Autism and Developmental Disorders, 2024
Sulforaphane has been reported to possibly improve core symptoms associated with autism spectrum disorders from mostly small size studies. Here we present results of a larger randomized clinical trial (N = 108) in China. There were no significant changes in caregiver rated scales between sulforaphane and placebo groups. However, clinician rated…
Descriptors: Drug Therapy, Outcomes of Treatment, Autism Spectrum Disorders, Randomized Controlled Trials
Lucy Beasant; Alba Realpe; Sarah Douglas; Lorcan Kenny; Dheeraj Rai; Nicola Mills – Autism: The International Journal of Research and Practice, 2024
The purpose of this study is to explore the views of autistic adults on randomised controlled trials, specifically on processes such as randomisation and blinding, to understand the barriers and facilitators for recruiting autistic people to randomised controlled trials involving medications. We conducted one-to-one interviews with 49 autistic…
Descriptors: Autism Spectrum Disorders, Adults, Attitudes, Randomized Controlled Trials
Frances R. Levin; John J. Mariani; Martina Pavlicova; C. Jean Choi; Cale Basaraba; Amy L. Mahony; Daniel J. Brooks; Christina A. Brezing; Nasir Naqvi – Journal of Attention Disorders, 2024
Objective: To determine if treatment of co-occurring adult ADHD and Cannabis Use Disorder (CUD) with extended-release mixed amphetamine salts (MAS-ER) would be effective at improving ADHD symptoms and promoting abstinence. Method: A 12-week randomized, double-blind, two-arm pilot feasibility trial of adults with comorbid ADHD and CUD (n = 28)…
Descriptors: Comorbidity, Attention Deficit Hyperactivity Disorder, Marijuana, Drug Abuse
Deborah M. Caldwell; Jennifer C. Palmer; Katie E. Webster; Sarah R. Davies; Hugo Hughes; Joseph Rona; Rachel Churchill; Sarah E. Hetrick; Nicky J. Welton – Prevention Science, 2025
Many randomized controlled trials have investigated the role of school-based prevention interventions to reduce symptoms of anxiety and depression in young people. Systematic reviews have subsequently demonstrated a small, beneficial effect of these interventions when compared to a combined control group including usual care, no intervention, or…
Descriptors: Depression (Psychology), Prevention, Randomized Controlled Trials, Symptoms (Individual Disorders)
Edoardo G. Ostinelli; Orestis Efthimiou; Yan Luo; Clara Miguel; Eirini Karyotaki; Pim Cuijpers; Toshi A. Furukawa; Georgia Salanti; Andrea Cipriani – Research Synthesis Methods, 2024
When studies use different scales to measure continuous outcomes, standardised mean differences (SMD) are required to meta-analyse the data. However, outcomes are often reported as endpoint or change from baseline scores. Combining corresponding SMDs can be problematic and available guidance advises against this practice. We aimed to examine the…
Descriptors: Network Analysis, Meta Analysis, Depression (Psychology), Regression (Statistics)